About Dr. Diary Co
Dr. Diary Co is a company based in Seoul (South Korea) founded in 2017. Dr. Diary Co has raised $12.22 million across 1 funding round from investors including Korea Investment Holdings, Shinhan Financial Group and Devsisters Ventures. Dr. Diary Co operates in a competitive market with competitors including BeatO, Glooko, Health2Sync, SocialDiabetes and Tidepool, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.22 M (USD)
in 1 rounds
-
Latest Funding Round
$12.22 M (USD), Series B
Mar 02, 2022
-
Investors
Korea Investment Holdings
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dr. Diary Co
Dr. Diary Co has successfully raised a total of $12.22M through 1 strategic funding round. The most recent funding activity was a Series B round of $12.22 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $12.2M
-
First Round
First Round
(02 Mar 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series B - Dr. Diary Co | Valuation | Devsisters Ventures , Shinhan Financial Group |
Investors in Dr. Diary Co
Dr. Diary Co has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Korea Investment Holdings, Shinhan Financial Group and Devsisters Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on early-stage companies in various sectors.
|
Founded Year | Domain | Location | |
|
Financial group
|
Founded Year | Domain | Location | |
|
Insight Equity is focused on middle market private equity investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dr. Diary Co
Financial Statements - Dr. Diary Co
Dr. Diary Co Comparisons
Competitors of Dr. Diary Co
Dr. Diary Co operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeatO, Glooko, Health2Sync, SocialDiabetes and Tidepool, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smartphone-enabled glucometers and diabetes management apps are provided.
|
|
| domain | founded_year | HQ Location |
Diabetes management is enabled via glucose meters and mobile apps.
|
|
| domain | founded_year | HQ Location |
Provider of an app for tracking blood glucose level
|
|
| domain | founded_year | HQ Location |
Mobile health solution that connects doctors and diabetic patients
|
|
| domain | founded_year | HQ Location |
SaaS for Type 1 diabetes management is provided by Tidepool.
|
Frequently Asked Questions about Dr. Diary Co
Dr. Diary Co was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Dr. Diary Co is headquartered in Seoul, South Korea.
Dr. Diary Co is a funded company, having raised a total of $12.22M across 1 funding round to date. The company's 1st funding round was a Series B of $12.22M, raised on Mar 02, 2022.
Provider of app for diabetes management. The application platform that helps patients to manage and record the blood glucose level. It allows patients to record the daily exercise routines, food supplements and gives insights on foods to manage glucose level. The app also consists of communication tools and personal consultation services with healthcare professionals.
Dr. Diary Co's top competitors include BeatO, Glooko and Health2Sync.
Dr. Diary Co has 6 investors. Key investors include Korea Investment Holdings, Shinhan Financial Group, Devsisters Ventures, Insight Equity, and Smile Gate Investment.